Rx · PZN 17440393, 17440401, 17440418

EMTRICITABIN-Tenofovirdisoproxil Laurus 200-245 mg

German trade nameEMTRICITABIN Tenofovirdisoproxil Laurus 200-245 mg

Active ingredientTenofovir disoproxil and emtricitabineSubstance (DE)Tenofovirdisoproxil und EmtricitabinPharmaceutical formFilm-coated tablets

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Average purchase price (B2B)

~ €51

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for EMTRICITABIN-Tenofovirdisoproxil Laurus 200-245 mg.

Review purchasing terms

EMTRICITABIN-Tenofovirdisoproxil Laurus 200-245 mg contains the active ingredient Tenofovir disoproxil and emtricitabine (German Tenofovirdisoproxil und Emtricitabin) and comes as Film-coated tablets. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.

Pack sizes · 3 PZN

PZN	Index 7 d	Index 30 d	Highest known purchase price
17440393	0.0	0.0	~ €26
17440401	0.0	0.0	~ €51
17440418	0.0	0.0	~ €77

According to the data available to us, EMTRICITABIN-Tenofovirdisoproxil Laurus 200-245 mg is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 3 recorded PZNs.